Viewing Study NCT04847050


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2026-01-22 @ 5:59 PM
Study NCT ID: NCT04847050
Status: COMPLETED
Last Update Posted: 2024-08-27
First Post: 2021-04-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor Malignancy View
None Hematologic Malignancy View
None Leukemia View
None Lymphoma View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None mRNA-1273 vaccine View
None moderna View
None SARS-CoV-2 View
None booster shot View